ATE198894T1 - 1,5 benzodiazepinoderivate mit cck- antagonisierender und oder agonisierender wirkung - Google Patents

1,5 benzodiazepinoderivate mit cck- antagonisierender und oder agonisierender wirkung

Info

Publication number
ATE198894T1
ATE198894T1 AT94913580T AT94913580T ATE198894T1 AT E198894 T1 ATE198894 T1 AT E198894T1 AT 94913580 T AT94913580 T AT 94913580T AT 94913580 T AT94913580 T AT 94913580T AT E198894 T1 ATE198894 T1 AT E198894T1
Authority
AT
Austria
Prior art keywords
agonizing
antagonizing
ccc
effects
benzodiazepine derivatives
Prior art date
Application number
AT94913580T
Other languages
English (en)
Inventor
Elizabeth Ellen Sugg
Christopher Joseph Aquino
Jerzy Ryszard Szewczyk
Harry Finch
Robin Arthur Ellis Carr
Original Assignee
Glaxo Wellcome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Wellcome Inc filed Critical Glaxo Wellcome Inc
Application granted granted Critical
Publication of ATE198894T1 publication Critical patent/ATE198894T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0207—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)4-C(=0), e.g. 'isosters', replacing two amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
AT94913580T 1993-04-15 1994-04-14 1,5 benzodiazepinoderivate mit cck- antagonisierender und oder agonisierender wirkung ATE198894T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939307833A GB9307833D0 (en) 1993-04-15 1993-04-15 Modulators of cholecystokinin and gastrin
PCT/EP1994/001131 WO1994024149A1 (en) 1993-04-15 1994-04-14 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity

Publications (1)

Publication Number Publication Date
ATE198894T1 true ATE198894T1 (de) 2001-02-15

Family

ID=10733915

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94913580T ATE198894T1 (de) 1993-04-15 1994-04-14 1,5 benzodiazepinoderivate mit cck- antagonisierender und oder agonisierender wirkung

Country Status (33)

Country Link
US (2) US5646140A (de)
EP (1) EP0694039B1 (de)
JP (1) JP3406317B2 (de)
KR (1) KR100364948B1 (de)
CN (1) CN1058487C (de)
AP (2) AP462A (de)
AT (1) ATE198894T1 (de)
AU (1) AU681139B2 (de)
CA (1) CA2158973C (de)
CZ (1) CZ286695B6 (de)
DE (1) DE69426624T2 (de)
DK (1) DK0694039T3 (de)
EC (1) ECSP941066A (de)
ES (1) ES2154674T3 (de)
FI (1) FI954853A0 (de)
GB (1) GB9307833D0 (de)
GR (1) GR3035641T3 (de)
HU (1) HU223467B1 (de)
IL (2) IL109316A (de)
IS (2) IS4148A (de)
MY (2) MY112237A (de)
NO (1) NO311133B1 (de)
NZ (1) NZ265272A (de)
OA (1) OA10355A (de)
PE (2) PE50594A1 (de)
PH (1) PH30897A (de)
PL (1) PL178790B1 (de)
PT (1) PT694039E (de)
RU (1) RU2135486C1 (de)
SK (1) SK281211B6 (de)
TW (1) TW487703B (de)
WO (1) WO1994024149A1 (de)
ZA (2) ZA942570B (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1073089C (zh) * 1993-12-28 2001-10-17 盐野义制药株式会社 苯并二氮杂噁衍生物、其组合物及其在药物制备中的用途
US5739129A (en) * 1994-04-14 1998-04-14 Glaxo Wellcome Inc. CCK or gastrin modulating 5-heterocyclic-1, 5 benzodiazepines
RU2152939C1 (ru) * 1994-04-14 2000-07-20 Глаксо Веллкам Инк. 5-гетероцикло-1,5-бензодиазепины и их фармацевтически приемлемые соли
PE27497A1 (es) * 1994-04-15 1997-08-07 Glaxo Inc Derivados de 1,5 benzodiazepina
JPH09511998A (ja) * 1994-04-15 1997-12-02 グラクソ、ウェルカム、インコーポレーテッド １，４ − ベンゾジアゼピン化合物を用いたコレシストキニンアゴニスト活性の誘導方法
US5780464A (en) * 1994-10-14 1998-07-14 Glaxo Wellcome Inc. Enteric coated compositions of 1,5-benzodiazepine derivatives having CCK antagonistic or agonistic activity
GB9420747D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
GB9420763D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc Acetamide derivatives
GB9420748D0 (en) * 1994-10-14 1994-11-30 Glaxo Inc 1,5 benzodiazepine derivatives
US5910495A (en) * 1994-10-14 1999-06-08 Glaxo Wellcome Inc. Use of 1,5-benzo b!1,4-diazepines to control gastric emptying
US5750353A (en) * 1995-12-11 1998-05-12 New England Medical Center Hospitals, Inc. Assay for non-peptide agonists to peptide hormone receptors
JP4442930B2 (ja) 1995-12-11 2010-03-31 タフツ メディカル センター インコーポレイテッド ペプチドホルモンレセプターリガンドに関するアッセイ法およびその使用
PT945445E (pt) * 1996-12-10 2004-01-30 Zeria Pharm Co Ltd Derivados de 1,5-benzodiazepina
GB2338235B (en) 1997-04-15 2001-11-14 Csir Appetite suppressing plant extracts
AR022044A1 (es) * 1999-05-06 2002-09-04 Glaxo Group Ltd Derivados de 1,5-benzodiazepina
GB2355657B (en) 1999-10-27 2004-07-28 Phytopharm Plc Inhibitors Of Gastric Acid Secretion
GB2363985B (en) 2000-06-30 2004-09-29 Phytopharm Plc Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
US6768024B1 (en) 2000-08-04 2004-07-27 Lion Bioscience Ag Triamine derivative melanocortin receptor ligands and methods of using same
US20020180095A1 (en) * 2001-05-29 2002-12-05 Berard Steven O. Thermally conductive carbon fiber extrusion compounder and method of using same
CA2476936A1 (en) * 2002-02-20 2003-08-28 Chih-Hung Lee Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
US7074805B2 (en) * 2002-02-20 2006-07-11 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US6933311B2 (en) * 2003-02-11 2005-08-23 Abbott Laboratories Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
US7015233B2 (en) 2003-06-12 2006-03-21 Abbott Laboratories Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
RU2261246C1 (ru) * 2004-04-15 2005-09-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Замещенные 7-сульфонил бензо[b][1,4]диазепины (варианты), способы их получения (варианты), фокусированная библиотека и фармацевтическая композиция
AP2006003768A0 (en) * 2004-05-25 2006-10-31 Pfizer Prod Inc TetraazabenzoÄeÜazulene derivatives and analogs tehereof
CN1333077C (zh) * 2005-04-15 2007-08-22 华南农业大学 缩胆囊素活性片段的串联表达及其应用
RU2303597C1 (ru) * 2006-05-12 2007-07-27 Иващенко Андрей Александрович Фармацевтическая композиция, способы ее получения и применения
CA2661898A1 (en) * 2006-08-25 2008-02-28 Abbott Laboratories Indazole derivatives that inhibit trpv1 and uses thereof
CA2672196A1 (en) 2006-12-20 2008-07-03 Abbott Laboratories Antagonists of the trpv1 receptor and uses thereof
EP2489660A1 (de) * 2008-03-20 2012-08-22 Abbott Laboratories Verfahren zum Herstellen von Mitteln für das zentrale Nervensystem, die TRPV1-Antagonisten sind
CN103102285B (zh) * 2013-01-30 2015-07-29 淮阴师范学院 对氨基苯乙腈的制备方法
RU2720237C2 (ru) 2013-11-18 2020-04-28 Форма Терапеутикс, Инк. Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет
CN110627770A (zh) 2013-11-18 2019-12-31 福马疗法公司 作为bet溴域抑制剂的四氢喹啉组成物
DK3324977T3 (da) 2015-07-22 2022-10-17 Enanta Pharm Inc Benzodiazepinderivater som rsv-inhibitorer
IL287136B2 (en) 2016-02-05 2023-09-01 Denali Therapeutics Inc Receptor inhibitors - interacting with protein kinase 1
JP7208137B2 (ja) 2016-12-09 2023-01-18 デナリ セラピューティクス インコーポレイテッド 化合物、組成物および方法
CN110809472B (zh) 2017-02-16 2023-05-23 英安塔制药有限公司 用于制备苯二氮䓬衍生物的方法
WO2018226801A1 (en) * 2017-06-07 2018-12-13 Enanta Pharmaceuticals, Inc. Aryldiazepine derivatives as rsv inhibitors
WO2019006291A1 (en) 2017-06-30 2019-01-03 Enanta Pharmaceuticals, Inc. HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS
US11091501B2 (en) 2017-06-30 2021-08-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as RSV inhibitors
BR112020006334A2 (pt) 2017-09-29 2020-09-24 Enanta Pharmaceuticals, Inc. combinação de agentes farmacêuticos como inibidores de rsv
US10647711B2 (en) 2017-11-13 2020-05-12 Enanta Pharmaceuticals, Inc. Azepin-2-one derivatives as RSV inhibitors
WO2019199908A1 (en) 2018-04-11 2019-10-17 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as rsv inhibitors
BR112021018335A2 (pt) 2019-03-18 2021-11-23 Enanta Pharm Inc Derivados de benzodiazepina como inibidores de rsv
WO2020210246A1 (en) 2019-04-09 2020-10-15 Enanta Pharmaceuticals, Inc, Heterocyclic compounds as rsv inhibitors
US11505558B1 (en) 2019-10-04 2022-11-22 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
UY39032A (es) 2020-01-24 2021-07-30 Enanta Pharm Inc Compuestos heterocíclicos como agentes antivirales
WO2022010882A1 (en) 2020-07-07 2022-01-13 Enanta Pharmaceuticals, Inc, Dihydroquinoxaline and dihydropyridopyrazine derivatives as rsv inhibitors
US11945824B2 (en) 2020-10-19 2024-04-02 Enanta Pharmaceuticals, Inc. Heterocyclic compounds as anti-viral agents
US12612412B2 (en) 2021-02-26 2026-04-28 Enanta Pharmaceuticals, Inc. Antiviral heterocyclic compounds
TW202334164A (zh) 2022-01-12 2023-09-01 美商戴納立製藥公司 （Ｓ）－５－苄基－Ｎ－（５－甲基－４－側氧基－２，３，４，５－四氫吡啶並［３，２－ｂ］［１，４］氧氮呯－３－基）－４Ｈ－１，２，４－三唑－３－甲醯胺的晶型
AR129003A1 (es) 2022-04-07 2024-07-03 Enanta Pharm Inc Compuestos heterocíclicos antivirales
WO2023211997A1 (en) 2022-04-27 2023-11-02 Enanta Pharmaceuticals, Inc. Antiviral compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517195A (en) * 1984-07-02 1985-05-14 Hoechst-Roussel Pharmaceuticals Inc. Pyrrolo[1,2-b][1,2,5]triazepines and pharmaceutical compositions thereof
FR2641280B1 (fr) * 1988-12-29 1994-01-21 Roussel Uclaf Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
SU1362732A1 (ru) * 1986-04-16 1987-12-30 Ленинградский Технологический Институт Им.Ленсовета Способ получени 2-диалкиламино-4-метил-3н-1,5-бензодиазепинов
CH673947A5 (de) * 1986-09-23 1990-04-30 Sandoz Ag
FR2659653B1 (fr) * 1990-03-13 1992-05-22 Rhone Poulenc Sante Derives de l'uree, leur preparation et les medicaments les contenant.
US5206234A (en) * 1990-10-22 1993-04-27 Merck & Co., Inc. Benzolactam analogs as antagonists of cck
JP2904941B2 (ja) * 1991-01-28 1999-06-14 出光興産株式会社 スチレン系重合体の精製方法
GB9201180D0 (en) * 1992-01-21 1992-03-11 Glaxo Group Ltd Chemical compounds
RU2152939C1 (ru) * 1994-04-14 2000-07-20 Глаксо Веллкам Инк. 5-гетероцикло-1,5-бензодиазепины и их фармацевтически приемлемые соли

Also Published As

Publication number Publication date
PT694039E (pt) 2001-06-29
PL311084A1 (en) 1996-02-05
FI954853A7 (fi) 1995-10-12
AU6567694A (en) 1994-11-08
TW487703B (en) 2002-05-21
CN1058487C (zh) 2000-11-15
EP0694039A1 (de) 1996-01-31
NO311133B1 (no) 2001-10-15
PH30897A (en) 1997-12-23
IL109316A0 (en) 1994-07-31
MY112237A (en) 2001-05-31
MY131569A (en) 2007-08-30
NO954090L (no) 1995-12-13
HU223467B1 (hu) 2004-07-28
AP462A (en) 1996-02-19
HU9502978D0 (en) 1995-12-28
NZ265272A (en) 1997-07-27
PL178790B1 (pl) 2000-06-30
IS4148A (is) 1994-10-16
SK281211B6 (sk) 2001-01-18
ZA942570B (en) 1994-11-11
DK0694039T3 (da) 2001-05-21
EP0694039B1 (de) 2001-01-24
IL109316A (en) 1999-03-12
OA10355A (en) 2001-10-19
NO954090D0 (no) 1995-10-13
PE50994A1 (es) 1995-01-06
WO1994024149A1 (en) 1994-10-27
JP3406317B2 (ja) 2003-05-12
AU681139B2 (en) 1997-08-21
US5585376A (en) 1996-12-17
CA2158973A1 (en) 1994-10-27
GR3035641T3 (en) 2001-06-29
HUT74102A (en) 1996-11-28
CA2158973C (en) 2006-06-06
AP9400635A0 (en) 1994-04-30
KR100364948B1 (ko) 2003-03-29
AP512A (en) 1996-07-29
FI954853L (fi) 1995-10-12
AP9400634A0 (en) 1994-04-30
ES2154674T3 (es) 2001-04-16
HK1003943A1 (en) 1998-11-13
DE69426624T2 (de) 2001-06-21
FI954853A0 (fi) 1995-10-12
ECSP941066A (es) 1994-11-16
IL109315A0 (en) 1994-07-31
RU2135486C1 (ru) 1999-08-27
PE50594A1 (es) 1995-01-06
ZA942571B (en) 1994-11-11
GB9307833D0 (en) 1993-06-02
IS4147A (is) 1994-10-16
JPH08508744A (ja) 1996-09-17
US5646140A (en) 1997-07-08
CN1120843A (zh) 1996-04-17
DE69426624D1 (de) 2001-03-01
SK125395A3 (en) 1996-06-05
CZ286695B6 (en) 2000-06-14
CZ267595A3 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
ATE198894T1 (de) 1,5 benzodiazepinoderivate mit cck- antagonisierender und oder agonisierender wirkung
FI962350L (fi) BPM-12, BMP-13 sekä niiden jännettä indusoivat koostumukset
NO942257D0 (no) Polymerer, samt anvendelse av dem
FI953489A0 (fi) 2,6-diaminopuriinijohdannaisia
FI953426A7 (fi) Biohajoavia kopolymeereja, menetelmä niiden valmistamiseksi ja niiden käyttö
DE69415163D1 (de) ZUZAMMENSETUNG ENTHALTEND 1,1,1,2,3,4,4,5,5,5,-DECAFLUORPENTAN UND n-PROPANOL
DE69425100D1 (de) Dynamisches neuronales Netzwerk
FI954979A7 (fi) Kemoherkistävinä aineina käytettävät 10,11-metanodibentsosuberaanijohdannaiset
FI943912L (fi) Tienopyrimidiinijohdannaiset, niiden valmistus ja käyttö
FI932615A0 (fi) Anordning foer minimering av virvelstroemmar i en magnetisk avbildningsapparat foersedd med polskor
EP0810864A4 (de) 2,6-diaryl pyridazinone mit immunosuppressiver wirkung
EP1012266A4 (de) Galectin 8, 9, 10 und 10sv.
FI952709A7 (fi) 1,4-bentsodiatsepiinijohdannaisia ja niiden käyttö cck-modulaattoreina
ZA945238B (en) 1,5 Benzodiazepine derivatives.
FI954386A0 (fi) (1,2,4)triatsolo(4,3-a)kinoksaalinijohdannaiset, niiden valmistus ja käyttö
DE69427286D1 (de) 7,42-bis (o-demethyl)rapamycin
DE69417979D1 (de) Polyisocyanat, blockiertes polyisocyanat und beschichtungszusammensetzung
DE69432590D1 (de) 1,2,3,4-tetrahydrochinolin-2,3,4-trion-3 oder 4-oxime und ihre verwendung
DE69635224D1 (de) 1,3-dihydro-2h-imidazol-2-on-derivate mit pdeiv und cytokin inhibierender aktivität
FI944563L (fi) Mikro-organismeja, valmistusmenetelmä ja käyttö
FI932396A7 (fi) Foerfarande foer framstaellning av en dubbelskyddad 2,3-hydroximetylcyklobutanol
EP0612904A3 (de) Scharniervorrichtung, seine Konstruktion und seine Verwendung.
FI930237L (fi) Foerfarande foer framstaellning av 4,6-dialkoxipyrimidiner
FI960026A7 (fi) Värejä, joissa on tetra-aminopyrimidiiniä ja suoravärjäysaineita
ITRM920520A1 (it) Granuli liofilizzati contenenti microorganismi fungini, e procedimento per la loro preparazione.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee